GlassScriptPhysician profile
Brian J Telesz
NPI 1447546833
$6,125.58
in general payments reported to CMS, 2019-2025
13 companies · $965 in 2025
The $965 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $17.73 · 2021: $491 · 2022: $426 · 2023: $1,990 · 2024: $1,836 · 2025: $965.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,643 · Travel and Lodging: $2,131 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,642.54 |
| Travel and Lodging | $2,130.71 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,946.06 | 2022-2024 | Mitraclip |
| Boston Scientific Corporation | $1,357.87 | 2021-2025 | Watchman Flx, Watchman Access System |
| Edwards Lifesciences Corporation | $826.70 | 2019-2025 | Evoque, Pascal, Konect Resilia |
| Cvrx, INC. | $329.07 | 2021-2022 | |
| Atricure, INC. | $171.04 | 2023-2025 | Synergy Ablation System |
| La Jolla Pharmaceutical Company | $152.30 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $74.46 | 2019 | |
| Merck Sharp & Dohme LLC | $64.79 | 2024-2025 | Bridion |
| Chiesi USA, INC. | $49.41 | 2022-2025 | Kengreal |
| Shockwave Medical, INC | $48.18 | 2022 | |
| Abiomed | $43.68 | 2025 | |
| Biosense Webster, INC. | $37.35 | 2022-2023 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.67 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Telesz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.